Found: 2
Select item for more details and to access through your institution.
BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 378, doi. 10.3390/cancers15020378
- By:
- Publication type:
- Article
Inhibition of BRAF and ERK1/2 has synergistic effects on thyroid cancer growth in vitro and in vivo.
- Published in:
- Molecular Carcinogenesis, 2021, v. 60, n. 3, p. 201, doi. 10.1002/mc.23284
- By:
- Publication type:
- Article